Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2022-07-05 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
独立董事关于公司第五届董事会第十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's fifth board of directors' eighteenth meeting. It references compliance with laws and regulations, and provides an independent opinion on a related party transaction involving the establishment of an investment fund. The document is short (622 characters) and does not contain financial statements or detailed financial data. It is a formal opinion related to board/management matters rather than a full report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG).
2022-07-05 Chinese
第五届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 阳普医疗科技股份有限公司 (Yangpu Medical Technology Co., Ltd.). It details decisions made by the board regarding investment fund establishment and internal restructuring of subsidiaries. The text includes meeting date, attendance, voting results, and references to related announcements on the regulatory disclosure website. There are no financial statements or detailed financial performance data presented. The document is a corporate governance announcement about board decisions rather than a full management report or financial report. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1773 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2022-07-05 Chinese
关于终止全资子公司之间吸收合并暨变更为全资子公司间收购股权的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 阳普医疗科技股份有限公司 regarding the termination of a planned absorption merger between its wholly-owned subsidiaries and the change to an internal acquisition of equity between these subsidiaries. It details the transaction parties, shareholding structure, financial data of the subsidiaries, and the terms of the equity transfer. The document explicitly states that this transaction is an internal equity adjustment and does not constitute a major asset restructuring or related party transaction requiring shareholder approval. The content focuses on corporate restructuring and internal share transfers rather than financial results, earnings, or regulatory compliance filings. It is not a full financial report, earnings release, or audit report. It is a formal announcement of a corporate transaction involving share transfers within subsidiaries. Therefore, the most appropriate classification is Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including internal equity transfers between subsidiaries.
2022-07-05 Chinese
关于公司与控股股东共同发起设立投资基金暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company and its controlling shareholder jointly initiating the establishment of an investment fund and related party transactions. It details the investment fund's structure, investment scope, management fees, decision-making mechanisms, and the impact on the company. It includes board and supervisory committee approvals and independent directors' opinions. There are no financial statements or quarterly/yearly financial results presented. The document is a formal announcement of a capital/financing update related to the establishment of an investment fund and related party transactions, not a full financial report or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-07-05 Chinese
第五届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the supervisory board of Yangpu Medical Technology Co., Ltd. It details decisions made in a specific board meeting, including approval of investment fund establishment and internal equity restructuring between subsidiaries. The document includes voting results and references to related announcements on a regulatory disclosure website. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an official announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short (1634 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2022-07-05 Chinese
独立董事关于公司第五届董事会第十八次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing prior approval opinions related to a specific board meeting agenda item concerning an investment fund and related party transaction. It references company governance rules and regulatory guidelines but does not contain financial statements or detailed financial data. The document is short (580 characters) and serves as a formal opinion or announcement related to board matters rather than a full management report or financial filing. This fits best under Board/Management Information (MANG), which covers announcements of changes or opinions from the board or senior management.
2022-07-05 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.